NYMC > News and Events > NYMC in the News

The Latest “Breakthrough Therapy”: Expensive New Drugs for Tardive Dyskinesia

November 15, 2020

Generic NYMC in the News LogoLeslie Citrome, a professor of psychiatry and behavioral sciences at New York Medical College, and colleagues put forth three arguments to support Neurocrine’s claim that only a small percentage of patients with TD have been diagnosed and treated.

Faculty news: Leslie L. Citrome, M.D., M.P.H., clinical professor of psychiatry and behavioral sciences

Source: Mad in America